Mphasis enters the first quarter of FY 2026-2027 with strong momentum, buoyed by a significant INR translation tailwind and a resilient BFSI-led business profile. Investors will be closely watching how the company balances this currency benefit against rising onshore talent costs and the ongoing investment requirements of its AI-led deal portfolio.
| Results date | July 23, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 4,242.7 Cr |
| Previous quarter PAT | Rs. 1,862.6 Cr |
| Previous quarter EBITDA margin | 18.94% |
| Market cap | Rs. 45,698.68 Cr |
| CMP | Rs. 2,394.2 |
The company has scheduled its board meeting for July 23, 2026, to consider the audited financial results.
Mphasis enters Q1 FY27 building on a strong Q4 exit rate, where revenue grew 14.4% YoY and 6.0% QoQ. The rupee's depreciation from an average of ~83 in Q1 FY26 to the 94–95 band in Q1 FY27 serves as a mechanical translation tailwind that supports the company's goal of growing revenue at more than double the industry rate. While management's EBIT margin guidance of 14.75–15.75% remains the anchor, the quarter faces pressure from the new H-1B wage-based selection system effective April 1, 2026, and the necessity of sustaining AI-led investments which comprised 64% of Q4 TCV. The upcoming call will likely focus on the bridge between reported INR growth and underlying constant-currency performance, alongside updates on whether the 47.6% YoY rise in trade receivables seen in FY26 is beginning to normalize.
Performance vs Guidance Tracking: Management's framework for FY27 remains consistent with the previous year's targets.
Operating metric trajectory: Key segment and financial health indicators from the latest reporting period.
Risks and headwinds to monitor: Management-flagged factors impacting current quarter margins.
The BFSI segment, which accounts for 54% of revenue, grew 23.9% YoY in Q4. EBIT margins for this segment expanded significantly by 486 bps to reach 34.1%.
Trade receivables reached Rs. 4,471.8 Cr in FY26, marking a 47.6% YoY increase. Management noted that the expected normalization of DSO to around 90 days did not materialize in Q4.
The rupee weakened to the 94–95 band in Q1 FY27 compared to an average of ~83 in Q1 FY26. Since the company earns 75–80% of its revenue in USD, this ~11–12% depreciation provides a mechanical lift to reported INR revenue and EBITDA margins.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now